EXP2670 PUR7776.pdf
PDF 149 KB Posted
- Attached to
- Sebia reagents and services
- Solicitation number
- SS-15959
- Issued by
- Leon County, Florida
About this file
This is a Description of Intended Single Source Purchase (PUR 7776) filed by the Florida Department of Health, Bureau of Public Health Laboratories (BPHL). The BPHL Newborn Screening Unit seeks to procure reagents, controls, calibrators, consumables, and services for the FDA-approved CAPILLARS 3 DBS automated analyzer to perform qualitative screening for detection of normal and abnormal hemoglobin in newborn dry blood samples. These components enable simultaneous testing of multiple parameters, improving accuracy for early screening of genetic and inheritable disorders in newborns. The contract term is three years. The posting date was May 13, 2026, with a deadline for receipt of information by June 3, 2026, at 1:30 PM. The requestor is Yasemin Sulker, Bureau of Public Health Laboratories, contact information: 850-245-4931 or Yasemin.Sulker@flhealth.gov. The internal tracking number is EXP2670.
The estimated dollar amount for this single source purchase is $2,695,571.00. The intended single source vendor is Sebia, Inc., identified as the sole manufacturer and distributor of the CAPILLARS 3 DBS automated analyzer and all proprietary reagents, controls, calibrators, and consumables. The justification for single source acquisition is based on Sebia's exclusive FDA approval for this specific analyzer system and the proprietary nature of the components, which ensures standardized, reliable, and scientifically validated diagnostic results necessary for patient care. The purchase was approved by Sonja German, Purchasing Director.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PUR 7776 (Revised 07/2022) Page 1 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.
DESCRIPTION OF INTENDED
SINGLE SOURCE PURCHASE
(PUR 7776)
This description of commodities or contractual services intended for purchase from a single source is posted in accordance with Sections 120.57(3) and 287.057(3), Florida Statutes (F.S.), and will remain posted for a period of at least 15 business days.
Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (NSPSC), manufacturer, model, and description, as appropriate):
41116105: Chemistry reagents or solutions
Quantity or Term (as appropriate):
Three years
Requestor (division, bureau, office, individual, as appropriate):
The Florida Department of Health, Bureau of Public Health Laboratories (BPHL)
Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate): The Department of Health, Bureau of Public Health Laboratories (BPHL), New born Screening Unit has the need to purchase reagents, controls, calibrators, consumables, and services for the FDA approved CAPILLARS 3 DBS automated analyzer, in order to test for qualitative screening for the detection of normal hemoglobin and abnormal hemoglobin using dry blood from human new-born, simultaneously. These components speed up dry blood sample testing and improve accuracy for early screening of genetic and inheritable disorders in newborns, ensuring the reliable results needed for immediate clinical intervention.
AGENCY: Florida Department of Health (FDOH)
TITLE: Sebia reagents and services Short description of the commodity or services desired: Reagents and equipment needed to perform validated testing of clinical samples.
CONTACT
Name: Yasemin Sulker Address: 4052 Bald Cypress Way, Tallahassee, FL 32399 Telephone: 850-245-4931 Email: Yasemin.Sulker@flhealth.gov.
Internal tracking number, if any: EXP2670
Date posted: 5/13/2026 at 1:30 PM Last day for receipt of information: 6/3/2026 at 1:30 PM mailto:Yasemin.Sulker@flhealth.gov
PUR 7776 (Revised 07/2022) Page 2 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.
In accordance with Chapter 60A-1.045, F.A.C. The Florida Department of Health, (BPHL), Newborn screening unit requests authorization to purchase as a single source, reagents, controls, calibrators, services, and consumables a from Sebia Inc.
Intended Single Source:
Sebia, Inc.
Estimated Dollar Amount:
$2,695,571.00
Justification for single source acquisition (what is necessary and unique about the product, services or source; steps taken to confirm unavailability of competition, as appropriate):
• Sebia’s CAPILLARS 3 DBS automated analyzer including all proprietary reagents, controls, calibrators, and consumables are the only FDA approved products that provide multiple testing simultaneously, ensuring that diagnostic results are standardized, reliable, and scientifically validated for patient care.
• Sebia, Inc is the sole manufacturer and distributor of the CAPILLARS 3 DBS automated analyzer including all proprietary reagents, controls, calibrators, and consumables.
Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):
Sonja German, Purchasing Director
Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Rule 60A-1.045, Florida Administrative Code, and section 120.57(3), F.S.
File details come from the government source that posted it. Updated .